Healthcare -
Biotechnology - NASDAQ - US
$ 11.2299
2.18 %
$ 595 M
Market Cap
-5.4
P/E
Price Target
Average
106.59%
Revenue Forecast
Estimate
131.28%
EBIT
Estimate
29.85%
Net Income
Estimate
12.46%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Stoke Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for STOK of $23.2 , with forecasts ranging from
a
low of
$18 to a high of $35 .
STOK Lowest Price Target
Wall Street Target
18 USD
60.29%
STOK Average Price Target
Wall Street Target
23.2 USD
106.59%
STOK Highest Price Target
Wall Street Target
35 USD
211.67%
REVENUE FORECAST
Revenue Forecast Chart STOK
EBIT FORECAST
EBIT Forecast Chart STOK
NET INCOME FORECAST
Net Income Chart STOK